nodes	percent_of_prediction	percent_of_DWPC	metapath
Desloratadine—CYP1A2—Pentoxifylline—systemic scleroderma	0.108	0.151	CbGbCtD
Desloratadine—CYP1A2—Leflunomide—systemic scleroderma	0.103	0.144	CbGbCtD
Desloratadine—ABCB1—Lisinopril—systemic scleroderma	0.0942	0.132	CbGbCtD
Desloratadine—CYP2C9—Leflunomide—systemic scleroderma	0.0926	0.13	CbGbCtD
Desloratadine—ABCB1—Captopril—systemic scleroderma	0.0705	0.0991	CbGbCtD
Desloratadine—CYP2D6—Captopril—systemic scleroderma	0.0665	0.0934	CbGbCtD
Desloratadine—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.0555	0.078	CbGbCtD
Desloratadine—CYP2C19—Prednisone—systemic scleroderma	0.055	0.0773	CbGbCtD
Desloratadine—ABCB1—Prednisone—systemic scleroderma	0.0444	0.0624	CbGbCtD
Desloratadine—ABCB1—Methotrexate—systemic scleroderma	0.0223	0.0313	CbGbCtD
Desloratadine—CYP2C9—cardial valve—systemic scleroderma	0.00812	0.644	CbGeAlD
Desloratadine—Dizziness—Pentoxifylline—systemic scleroderma	0.000682	0.00247	CcSEcCtD
Desloratadine—Decreased appetite—Captopril—systemic scleroderma	0.000679	0.00246	CcSEcCtD
Desloratadine—Hallucination—Mycophenolate mofetil—systemic scleroderma	0.000679	0.00246	CcSEcCtD
Desloratadine—Erythema—Lisinopril—systemic scleroderma	0.000678	0.00246	CcSEcCtD
Desloratadine—Infection—Azathioprine—systemic scleroderma	0.000677	0.00246	CcSEcCtD
Desloratadine—Pharyngitis—Mycophenolate mofetil—systemic scleroderma	0.000677	0.00246	CcSEcCtD
Desloratadine—Fatigue—Captopril—systemic scleroderma	0.000674	0.00244	CcSEcCtD
Desloratadine—Myalgia—Leflunomide—systemic scleroderma	0.000672	0.00244	CcSEcCtD
Desloratadine—Connective tissue disorder—Mycophenolate mofetil—systemic scleroderma	0.000671	0.00243	CcSEcCtD
Desloratadine—Palpitations—Mycophenolic acid—systemic scleroderma	0.000665	0.00241	CcSEcCtD
Desloratadine—Affect lability—Prednisone—systemic scleroderma	0.000658	0.00239	CcSEcCtD
Desloratadine—Dry mouth—Leflunomide—systemic scleroderma	0.000657	0.00238	CcSEcCtD
Desloratadine—Cough—Mycophenolic acid—systemic scleroderma	0.000657	0.00238	CcSEcCtD
Desloratadine—Vomiting—Pentoxifylline—systemic scleroderma	0.000656	0.00238	CcSEcCtD
Desloratadine—Convulsion—Mycophenolic acid—systemic scleroderma	0.000652	0.00237	CcSEcCtD
Desloratadine—Rash—Pentoxifylline—systemic scleroderma	0.00065	0.00236	CcSEcCtD
Desloratadine—Dermatitis—Pentoxifylline—systemic scleroderma	0.00065	0.00236	CcSEcCtD
Desloratadine—Headache—Pentoxifylline—systemic scleroderma	0.000646	0.00234	CcSEcCtD
Desloratadine—Anaphylactic shock—Leflunomide—systemic scleroderma	0.000644	0.00234	CcSEcCtD
Desloratadine—Myalgia—Mycophenolic acid—systemic scleroderma	0.000641	0.00232	CcSEcCtD
Desloratadine—Infection—Leflunomide—systemic scleroderma	0.00064	0.00232	CcSEcCtD
Desloratadine—Gastrointestinal pain—Captopril—systemic scleroderma	0.000639	0.00232	CcSEcCtD
Desloratadine—Asthenia—Mometasone—systemic scleroderma	0.000638	0.00232	CcSEcCtD
Desloratadine—Irritability—Prednisone—systemic scleroderma	0.000638	0.00232	CcSEcCtD
Desloratadine—Mood swings—Prednisone—systemic scleroderma	0.000633	0.0023	CcSEcCtD
Desloratadine—Cardiac disorder—Mycophenolate mofetil—systemic scleroderma	0.000633	0.0023	CcSEcCtD
Desloratadine—Nervous system disorder—Leflunomide—systemic scleroderma	0.000632	0.00229	CcSEcCtD
Desloratadine—Pruritus—Mometasone—systemic scleroderma	0.000629	0.00228	CcSEcCtD
Desloratadine—Tachycardia—Leflunomide—systemic scleroderma	0.000629	0.00228	CcSEcCtD
Desloratadine—Dry mouth—Mycophenolic acid—systemic scleroderma	0.000627	0.00227	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.000621	0.00225	CcSEcCtD
Desloratadine—Angioedema—Lisinopril—systemic scleroderma	0.00062	0.00225	CcSEcCtD
Desloratadine—Body temperature increased—Captopril—systemic scleroderma	0.000618	0.00224	CcSEcCtD
Desloratadine—Abdominal pain—Captopril—systemic scleroderma	0.000618	0.00224	CcSEcCtD
Desloratadine—Oedema—Mycophenolic acid—systemic scleroderma	0.000614	0.00223	CcSEcCtD
Desloratadine—Anorexia—Leflunomide—systemic scleroderma	0.000614	0.00223	CcSEcCtD
Desloratadine—Nausea—Pentoxifylline—systemic scleroderma	0.000612	0.00222	CcSEcCtD
Desloratadine—Infection—Mycophenolic acid—systemic scleroderma	0.00061	0.00221	CcSEcCtD
Desloratadine—Diarrhoea—Mometasone—systemic scleroderma	0.000609	0.00221	CcSEcCtD
Desloratadine—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.000603	0.00219	CcSEcCtD
Desloratadine—Tachycardia—Mycophenolic acid—systemic scleroderma	0.0006	0.00217	CcSEcCtD
Desloratadine—Palpitations—Lisinopril—systemic scleroderma	0.000599	0.00217	CcSEcCtD
Desloratadine—Mental disorder—Mycophenolate mofetil—systemic scleroderma	0.000598	0.00217	CcSEcCtD
Desloratadine—Cough—Lisinopril—systemic scleroderma	0.000592	0.00215	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.000589	0.00214	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.000587	0.00213	CcSEcCtD
Desloratadine—Anorexia—Mycophenolic acid—systemic scleroderma	0.000586	0.00212	CcSEcCtD
Desloratadine—Insomnia—Leflunomide—systemic scleroderma	0.000582	0.00211	CcSEcCtD
Desloratadine—Myalgia—Lisinopril—systemic scleroderma	0.000577	0.00209	CcSEcCtD
Desloratadine—Dyspnoea—Leflunomide—systemic scleroderma	0.000574	0.00208	CcSEcCtD
Desloratadine—Dyspepsia—Leflunomide—systemic scleroderma	0.000567	0.00206	CcSEcCtD
Desloratadine—Vomiting—Mometasone—systemic scleroderma	0.000566	0.00205	CcSEcCtD
Desloratadine—Dry mouth—Lisinopril—systemic scleroderma	0.000565	0.00205	CcSEcCtD
Desloratadine—Rash—Mometasone—systemic scleroderma	0.000561	0.00203	CcSEcCtD
Desloratadine—Asthenia—Captopril—systemic scleroderma	0.000561	0.00203	CcSEcCtD
Desloratadine—Dermatitis—Mometasone—systemic scleroderma	0.00056	0.00203	CcSEcCtD
Desloratadine—Decreased appetite—Leflunomide—systemic scleroderma	0.00056	0.00203	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.00056	0.00203	CcSEcCtD
Desloratadine—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000558	0.00202	CcSEcCtD
Desloratadine—Headache—Mometasone—systemic scleroderma	0.000557	0.00202	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000556	0.00202	CcSEcCtD
Desloratadine—Insomnia—Mycophenolic acid—systemic scleroderma	0.000556	0.00202	CcSEcCtD
Desloratadine—Fatigue—Leflunomide—systemic scleroderma	0.000555	0.00201	CcSEcCtD
Desloratadine—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000553	0.00201	CcSEcCtD
Desloratadine—Oedema—Lisinopril—systemic scleroderma	0.000553	0.00201	CcSEcCtD
Desloratadine—Pruritus—Captopril—systemic scleroderma	0.000553	0.00201	CcSEcCtD
Desloratadine—Infection—Lisinopril—systemic scleroderma	0.00055	0.00199	CcSEcCtD
Desloratadine—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000548	0.00199	CcSEcCtD
Desloratadine—Somnolence—Mycophenolic acid—systemic scleroderma	0.000546	0.00198	CcSEcCtD
Desloratadine—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000546	0.00198	CcSEcCtD
Desloratadine—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.000543	0.00197	CcSEcCtD
Desloratadine—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000541	0.00196	CcSEcCtD
Desloratadine—Tachycardia—Lisinopril—systemic scleroderma	0.00054	0.00196	CcSEcCtD
Desloratadine—Abdominal pain—Azathioprine—systemic scleroderma	0.000539	0.00196	CcSEcCtD
Desloratadine—Body temperature increased—Azathioprine—systemic scleroderma	0.000539	0.00196	CcSEcCtD
Desloratadine—Diarrhoea—Captopril—systemic scleroderma	0.000535	0.00194	CcSEcCtD
Desloratadine—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000534	0.00194	CcSEcCtD
Desloratadine—Irritability—Methotrexate—systemic scleroderma	0.000533	0.00193	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.00053	0.00192	CcSEcCtD
Desloratadine—Fatigue—Mycophenolic acid—systemic scleroderma	0.00053	0.00192	CcSEcCtD
Desloratadine—Mood swings—Methotrexate—systemic scleroderma	0.000529	0.00192	CcSEcCtD
Desloratadine—Nausea—Mometasone—systemic scleroderma	0.000528	0.00192	CcSEcCtD
Desloratadine—Anorexia—Lisinopril—systemic scleroderma	0.000527	0.00191	CcSEcCtD
Desloratadine—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000527	0.00191	CcSEcCtD
Desloratadine—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000525	0.0019	CcSEcCtD
Desloratadine—Cough—Mycophenolate mofetil—systemic scleroderma	0.000518	0.00188	CcSEcCtD
Desloratadine—Dizziness—Captopril—systemic scleroderma	0.000517	0.00187	CcSEcCtD
Desloratadine—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000515	0.00187	CcSEcCtD
Desloratadine—ABCB1—blood vessel—systemic scleroderma	0.000512	0.0406	CbGeAlD
Desloratadine—Urticaria—Leflunomide—systemic scleroderma	0.000512	0.00186	CcSEcCtD
Desloratadine—Abdominal pain—Leflunomide—systemic scleroderma	0.000509	0.00185	CcSEcCtD
Desloratadine—Body temperature increased—Leflunomide—systemic scleroderma	0.000509	0.00185	CcSEcCtD
Desloratadine—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000506	0.00183	CcSEcCtD
Desloratadine—Breast disorder—Methotrexate—systemic scleroderma	0.000505	0.00183	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000504	0.00183	CcSEcCtD
Desloratadine—Hypersensitivity—Azathioprine—systemic scleroderma	0.000502	0.00182	CcSEcCtD
Desloratadine—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000502	0.00182	CcSEcCtD
Desloratadine—Insomnia—Lisinopril—systemic scleroderma	0.000501	0.00182	CcSEcCtD
Desloratadine—Vomiting—Captopril—systemic scleroderma	0.000497	0.0018	CcSEcCtD
Desloratadine—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000495	0.00179	CcSEcCtD
Desloratadine—Dyspnoea—Lisinopril—systemic scleroderma	0.000493	0.00179	CcSEcCtD
Desloratadine—Rash—Captopril—systemic scleroderma	0.000493	0.00179	CcSEcCtD
Desloratadine—Dermatitis—Captopril—systemic scleroderma	0.000492	0.00179	CcSEcCtD
Desloratadine—Somnolence—Lisinopril—systemic scleroderma	0.000492	0.00178	CcSEcCtD
Desloratadine—Headache—Captopril—systemic scleroderma	0.00049	0.00178	CcSEcCtD
Desloratadine—Dyspepsia—Lisinopril—systemic scleroderma	0.000487	0.00177	CcSEcCtD
Desloratadine—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000486	0.00176	CcSEcCtD
Desloratadine—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000486	0.00176	CcSEcCtD
Desloratadine—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000485	0.00176	CcSEcCtD
Desloratadine—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000485	0.00176	CcSEcCtD
Desloratadine—Infection—Mycophenolate mofetil—systemic scleroderma	0.000482	0.00175	CcSEcCtD
Desloratadine—Decreased appetite—Lisinopril—systemic scleroderma	0.000481	0.00174	CcSEcCtD
Desloratadine—HRH1—connective tissue—systemic scleroderma	0.00048	0.038	CbGeAlD
Desloratadine—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000478	0.00173	CcSEcCtD
Desloratadine—Fatigue—Lisinopril—systemic scleroderma	0.000477	0.00173	CcSEcCtD
Desloratadine—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000475	0.00172	CcSEcCtD
Desloratadine—Hypersensitivity—Leflunomide—systemic scleroderma	0.000474	0.00172	CcSEcCtD
Desloratadine—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000473	0.00172	CcSEcCtD
Desloratadine—Diarrhoea—Azathioprine—systemic scleroderma	0.000467	0.00169	CcSEcCtD
Desloratadine—Nausea—Captopril—systemic scleroderma	0.000464	0.00168	CcSEcCtD
Desloratadine—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000462	0.00168	CcSEcCtD
Desloratadine—Asthenia—Leflunomide—systemic scleroderma	0.000462	0.00168	CcSEcCtD
Desloratadine—Hallucination—Prednisone—systemic scleroderma	0.00046	0.00167	CcSEcCtD
Desloratadine—Pruritus—Leflunomide—systemic scleroderma	0.000456	0.00165	CcSEcCtD
Desloratadine—Connective tissue disorder—Prednisone—systemic scleroderma	0.000455	0.00165	CcSEcCtD
Desloratadine—CYP2C19—digestive system—systemic scleroderma	0.000453	0.0359	CbGeAlD
Desloratadine—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000453	0.00164	CcSEcCtD
Desloratadine—Dizziness—Azathioprine—systemic scleroderma	0.000451	0.00164	CcSEcCtD
Desloratadine—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.000449	0.00163	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000442	0.0016	CcSEcCtD
Desloratadine—Asthenia—Mycophenolic acid—systemic scleroderma	0.000441	0.0016	CcSEcCtD
Desloratadine—Diarrhoea—Leflunomide—systemic scleroderma	0.000441	0.0016	CcSEcCtD
Desloratadine—Urticaria—Lisinopril—systemic scleroderma	0.00044	0.00159	CcSEcCtD
Desloratadine—HRH1—smooth muscle tissue—systemic scleroderma	0.000439	0.0348	CbGeAlD
Desloratadine—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000439	0.00159	CcSEcCtD
Desloratadine—Abdominal pain—Lisinopril—systemic scleroderma	0.000437	0.00159	CcSEcCtD
Desloratadine—Body temperature increased—Lisinopril—systemic scleroderma	0.000437	0.00159	CcSEcCtD
Desloratadine—Pruritus—Mycophenolic acid—systemic scleroderma	0.000435	0.00158	CcSEcCtD
Desloratadine—Vomiting—Azathioprine—systemic scleroderma	0.000434	0.00157	CcSEcCtD
Desloratadine—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000432	0.00157	CcSEcCtD
Desloratadine—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000431	0.00156	CcSEcCtD
Desloratadine—Infestation NOS—Methotrexate—systemic scleroderma	0.000431	0.00156	CcSEcCtD
Desloratadine—Infestation—Methotrexate—systemic scleroderma	0.000431	0.00156	CcSEcCtD
Desloratadine—Rash—Azathioprine—systemic scleroderma	0.00043	0.00156	CcSEcCtD
Desloratadine—Dermatitis—Azathioprine—systemic scleroderma	0.00043	0.00156	CcSEcCtD
Desloratadine—Headache—Azathioprine—systemic scleroderma	0.000427	0.00155	CcSEcCtD
Desloratadine—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000427	0.00155	CcSEcCtD
Desloratadine—Dizziness—Leflunomide—systemic scleroderma	0.000426	0.00154	CcSEcCtD
Desloratadine—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000421	0.00153	CcSEcCtD
Desloratadine—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.00042	0.00152	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000419	0.00152	CcSEcCtD
Desloratadine—Vomiting—Leflunomide—systemic scleroderma	0.000409	0.00149	CcSEcCtD
Desloratadine—Hypersensitivity—Lisinopril—systemic scleroderma	0.000408	0.00148	CcSEcCtD
Desloratadine—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000407	0.00148	CcSEcCtD
Desloratadine—Dizziness—Mycophenolic acid—systemic scleroderma	0.000406	0.00147	CcSEcCtD
Desloratadine—Epistaxis—Methotrexate—systemic scleroderma	0.000406	0.00147	CcSEcCtD
Desloratadine—Rash—Leflunomide—systemic scleroderma	0.000406	0.00147	CcSEcCtD
Desloratadine—Dermatitis—Leflunomide—systemic scleroderma	0.000406	0.00147	CcSEcCtD
Desloratadine—Mental disorder—Prednisone—systemic scleroderma	0.000405	0.00147	CcSEcCtD
Desloratadine—Nausea—Azathioprine—systemic scleroderma	0.000405	0.00147	CcSEcCtD
Desloratadine—Headache—Leflunomide—systemic scleroderma	0.000403	0.00146	CcSEcCtD
Desloratadine—Erythema—Prednisone—systemic scleroderma	0.000403	0.00146	CcSEcCtD
Desloratadine—Asthenia—Lisinopril—systemic scleroderma	0.000397	0.00144	CcSEcCtD
Desloratadine—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000396	0.00144	CcSEcCtD
Desloratadine—Pruritus—Lisinopril—systemic scleroderma	0.000392	0.00142	CcSEcCtD
Desloratadine—Vomiting—Mycophenolic acid—systemic scleroderma	0.000391	0.00142	CcSEcCtD
Desloratadine—Rash—Mycophenolic acid—systemic scleroderma	0.000387	0.00141	CcSEcCtD
Desloratadine—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000387	0.0014	CcSEcCtD
Desloratadine—Hepatitis—Methotrexate—systemic scleroderma	0.000387	0.0014	CcSEcCtD
Desloratadine—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000385	0.0014	CcSEcCtD
Desloratadine—Headache—Mycophenolic acid—systemic scleroderma	0.000385	0.0014	CcSEcCtD
Desloratadine—Pharyngitis—Methotrexate—systemic scleroderma	0.000384	0.00139	CcSEcCtD
Desloratadine—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000383	0.00139	CcSEcCtD
Desloratadine—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000383	0.00139	CcSEcCtD
Desloratadine—Nausea—Leflunomide—systemic scleroderma	0.000383	0.00139	CcSEcCtD
Desloratadine—Diarrhoea—Lisinopril—systemic scleroderma	0.000379	0.00137	CcSEcCtD
Desloratadine—CYP1A2—digestive system—systemic scleroderma	0.00037	0.0294	CbGeAlD
Desloratadine—Agitation—Prednisone—systemic scleroderma	0.00037	0.00134	CcSEcCtD
Desloratadine—Angioedema—Prednisone—systemic scleroderma	0.000368	0.00133	CcSEcCtD
Desloratadine—Dizziness—Lisinopril—systemic scleroderma	0.000366	0.00133	CcSEcCtD
Desloratadine—Nausea—Mycophenolic acid—systemic scleroderma	0.000365	0.00132	CcSEcCtD
Desloratadine—Cardiac disorder—Methotrexate—systemic scleroderma	0.000359	0.0013	CcSEcCtD
Desloratadine—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000357	0.0013	CcSEcCtD
Desloratadine—Vomiting—Lisinopril—systemic scleroderma	0.000352	0.00128	CcSEcCtD
Desloratadine—CYP2C9—digestive system—systemic scleroderma	0.000352	0.0279	CbGeAlD
Desloratadine—Rash—Lisinopril—systemic scleroderma	0.000349	0.00127	CcSEcCtD
Desloratadine—Convulsion—Prednisone—systemic scleroderma	0.000349	0.00127	CcSEcCtD
Desloratadine—Dermatitis—Lisinopril—systemic scleroderma	0.000349	0.00126	CcSEcCtD
Desloratadine—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000348	0.00126	CcSEcCtD
Desloratadine—HRH1—digestive system—systemic scleroderma	0.000347	0.0275	CbGeAlD
Desloratadine—Headache—Lisinopril—systemic scleroderma	0.000347	0.00126	CcSEcCtD
Desloratadine—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000343	0.00124	CcSEcCtD
Desloratadine—Myalgia—Prednisone—systemic scleroderma	0.000343	0.00124	CcSEcCtD
Desloratadine—Mental disorder—Methotrexate—systemic scleroderma	0.000339	0.00123	CcSEcCtD
Desloratadine—Erythema—Methotrexate—systemic scleroderma	0.000337	0.00122	CcSEcCtD
Desloratadine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000332	0.0012	CcSEcCtD
Desloratadine—HRH1—tendon—systemic scleroderma	0.00033	0.0262	CbGeAlD
Desloratadine—Nausea—Lisinopril—systemic scleroderma	0.000329	0.00119	CcSEcCtD
Desloratadine—Oedema—Prednisone—systemic scleroderma	0.000329	0.00119	CcSEcCtD
Desloratadine—Anaphylactic shock—Prednisone—systemic scleroderma	0.000329	0.00119	CcSEcCtD
Desloratadine—Infection—Prednisone—systemic scleroderma	0.000327	0.00118	CcSEcCtD
Desloratadine—Nervous system disorder—Prednisone—systemic scleroderma	0.000322	0.00117	CcSEcCtD
Desloratadine—Tachycardia—Prednisone—systemic scleroderma	0.000321	0.00116	CcSEcCtD
Desloratadine—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000321	0.00116	CcSEcCtD
Desloratadine—Anorexia—Prednisone—systemic scleroderma	0.000313	0.00114	CcSEcCtD
Desloratadine—CYP1A2—lung—systemic scleroderma	0.000309	0.0245	CbGeAlD
Desloratadine—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000308	0.00112	CcSEcCtD
Desloratadine—Rash—Mycophenolate mofetil—systemic scleroderma	0.000306	0.00111	CcSEcCtD
Desloratadine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000305	0.00111	CcSEcCtD
Desloratadine—Headache—Mycophenolate mofetil—systemic scleroderma	0.000304	0.0011	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000299	0.00109	CcSEcCtD
Desloratadine—Insomnia—Prednisone—systemic scleroderma	0.000297	0.00108	CcSEcCtD
Desloratadine—Cough—Methotrexate—systemic scleroderma	0.000294	0.00107	CcSEcCtD
Desloratadine—Convulsion—Methotrexate—systemic scleroderma	0.000292	0.00106	CcSEcCtD
Desloratadine—HRH1—lung—systemic scleroderma	0.00029	0.023	CbGeAlD
Desloratadine—Dyspepsia—Prednisone—systemic scleroderma	0.000289	0.00105	CcSEcCtD
Desloratadine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000288	0.00104	CcSEcCtD
Desloratadine—Myalgia—Methotrexate—systemic scleroderma	0.000287	0.00104	CcSEcCtD
Desloratadine—Decreased appetite—Prednisone—systemic scleroderma	0.000286	0.00104	CcSEcCtD
Desloratadine—Fatigue—Prednisone—systemic scleroderma	0.000283	0.00103	CcSEcCtD
Desloratadine—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000275	0.000996	CcSEcCtD
Desloratadine—Infection—Methotrexate—systemic scleroderma	0.000273	0.00099	CcSEcCtD
Desloratadine—Nervous system disorder—Methotrexate—systemic scleroderma	0.000269	0.000977	CcSEcCtD
Desloratadine—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000269	0.000975	CcSEcCtD
Desloratadine—CYP2D6—digestive system—systemic scleroderma	0.000264	0.0209	CbGeAlD
Desloratadine—Anorexia—Methotrexate—systemic scleroderma	0.000262	0.00095	CcSEcCtD
Desloratadine—Urticaria—Prednisone—systemic scleroderma	0.000261	0.000947	CcSEcCtD
Desloratadine—Body temperature increased—Prednisone—systemic scleroderma	0.00026	0.000942	CcSEcCtD
Desloratadine—Abdominal pain—Prednisone—systemic scleroderma	0.00026	0.000942	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.00025	0.000908	CcSEcCtD
Desloratadine—Insomnia—Methotrexate—systemic scleroderma	0.000248	0.000901	CcSEcCtD
Desloratadine—Dyspnoea—Methotrexate—systemic scleroderma	0.000245	0.000888	CcSEcCtD
Desloratadine—Somnolence—Methotrexate—systemic scleroderma	0.000244	0.000886	CcSEcCtD
Desloratadine—Hypersensitivity—Prednisone—systemic scleroderma	0.000242	0.000878	CcSEcCtD
Desloratadine—Dyspepsia—Methotrexate—systemic scleroderma	0.000242	0.000877	CcSEcCtD
Desloratadine—Decreased appetite—Methotrexate—systemic scleroderma	0.000239	0.000866	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000237	0.00086	CcSEcCtD
Desloratadine—Fatigue—Methotrexate—systemic scleroderma	0.000237	0.000859	CcSEcCtD
Desloratadine—Asthenia—Prednisone—systemic scleroderma	0.000236	0.000855	CcSEcCtD
Desloratadine—Pruritus—Prednisone—systemic scleroderma	0.000233	0.000843	CcSEcCtD
Desloratadine—Diarrhoea—Prednisone—systemic scleroderma	0.000225	0.000816	CcSEcCtD
Desloratadine—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000225	0.000815	CcSEcCtD
Desloratadine—Urticaria—Methotrexate—systemic scleroderma	0.000218	0.000791	CcSEcCtD
Desloratadine—Dizziness—Prednisone—systemic scleroderma	0.000217	0.000788	CcSEcCtD
Desloratadine—Body temperature increased—Methotrexate—systemic scleroderma	0.000217	0.000788	CcSEcCtD
Desloratadine—Abdominal pain—Methotrexate—systemic scleroderma	0.000217	0.000788	CcSEcCtD
Desloratadine—Vomiting—Prednisone—systemic scleroderma	0.000209	0.000758	CcSEcCtD
Desloratadine—Rash—Prednisone—systemic scleroderma	0.000207	0.000752	CcSEcCtD
Desloratadine—Dermatitis—Prednisone—systemic scleroderma	0.000207	0.000751	CcSEcCtD
Desloratadine—Headache—Prednisone—systemic scleroderma	0.000206	0.000747	CcSEcCtD
Desloratadine—Hypersensitivity—Methotrexate—systemic scleroderma	0.000202	0.000734	CcSEcCtD
Desloratadine—Asthenia—Methotrexate—systemic scleroderma	0.000197	0.000715	CcSEcCtD
Desloratadine—Nausea—Prednisone—systemic scleroderma	0.000195	0.000708	CcSEcCtD
Desloratadine—Pruritus—Methotrexate—systemic scleroderma	0.000194	0.000705	CcSEcCtD
Desloratadine—ABCB1—digestive system—systemic scleroderma	0.00019	0.015	CbGeAlD
Desloratadine—Diarrhoea—Methotrexate—systemic scleroderma	0.000188	0.000682	CcSEcCtD
Desloratadine—Dizziness—Methotrexate—systemic scleroderma	0.000182	0.000659	CcSEcCtD
Desloratadine—Vomiting—Methotrexate—systemic scleroderma	0.000175	0.000633	CcSEcCtD
Desloratadine—Rash—Methotrexate—systemic scleroderma	0.000173	0.000628	CcSEcCtD
Desloratadine—Dermatitis—Methotrexate—systemic scleroderma	0.000173	0.000628	CcSEcCtD
Desloratadine—Headache—Methotrexate—systemic scleroderma	0.000172	0.000624	CcSEcCtD
Desloratadine—Nausea—Methotrexate—systemic scleroderma	0.000163	0.000592	CcSEcCtD
Desloratadine—ABCB1—lung—systemic scleroderma	0.000158	0.0126	CbGeAlD
